TAM
REGN icon

Tocqueville Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Tocqueville Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Sell
3,315
-12,464
-79% -$8.48M 0.03% 298
2026
Q1 		$12.2M Sell
15,779
-31,045
-66% -$23.8M 0.18% 140
2025
Q4 		$36.1M Sell
46,824
-7,394
-14% -$5.02M 0.53% 45
2025
Q3 		$30.5M Sell
54,218
-6,884
-11% -$3.89M 0.44% 56
2025
Q2 		$32.1M Sell
61,102
-24,827
-29% -$13.9M 0.49% 55
2025
Q1 		$54.5M Buy
+85,929
New +$59.1M 0.89% 23
2018
Q1 		– Sell
-10,138
Closed -$3.81M – 859
2017
Q4 		$3.81M Sell
10,138
-240
-2% -$97.2K 0.04% 365
2017
Q3 		$4.64M Sell
10,378
-282
-3% -$134K 0.05% 329
2017
Q2 		$5.24M Hold
10,660
– – 0.06% 285
2017
Q1 		$4.13M Sell
10,660
-4,735
-31% -$1.76M 0.05% 325
2016
Q4 		$5.65M Buy
15,395
+130
+0.9% +$49.4K 0.07% 260
2016
Q3 		$6.14M Buy
15,265
+2,725
+22% +$1.09M 0.07% 257
2016
Q2 		$4.38M Sell
12,540
-890
-7% -$343K 0.05% 308
2016
Q1 		$4.84M Sell
13,430
-11,390
-46% -$4.69M 0.06% 282
2015
Q4 		$13.5M Sell
24,820
-270
-1% -$146K 0.18% 151
2015
Q3 		$11.7M Buy
25,090
+8,445
+51% +$4.54M 0.16% 178
2015
Q2 		$8.49M Buy
16,645
+325
+2% +$159K 0.1% 227
2015
Q1 		$7.37M Buy
16,320
+5
+0% +$2.12K 0.09% 250
2014
Q4 		$6.69M Sell
16,315
-890
-5% -$350K 0.07% 276
2014
Q3 		$6.2M Sell
17,205
-225
-1% -$75.4K 0.07% 259
2014
Q2 		$4.92M Buy
17,430
+500
+3% +$148K 0.05% 316
2014
Q1 		$5.08M Buy
16,930
+100
+0.6% +$30.8K 0.07% 252
2013
Q4 		$4.63M Buy
16,830
+1,635
+11% +$470K 0.06% 264
2013
Q3 		$4.75M Buy
15,195
+5,770
+61% +$1.52M 0.06% 305
2013
Q2 		$2.12M Buy
+9,425
New +$2.19M 0.03% 410

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tocqueville Asset Management's REGN Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 79% in Q2 2026, selling an estimated $8.48M and leaving 3,315 shares worth $2.07M. The position accounts for 0.03% of the portfolio, ranked #298.

Tocqueville Asset Management first reported a position in REGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $54.5M in Q1 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Tocqueville Asset Management held 3,315 shares of Regeneron Pharmaceuticals worth $2.07M as of Q2 2026.
  • Tocqueville Asset Management sold 12,464 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.48M.
  • Regeneron Pharmaceuticals made up 0.03% of Tocqueville Asset Management's portfolio in Q2 2026, its #298 holding.
  • Tocqueville Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
  • Tocqueville Asset Management's Regeneron Pharmaceuticals position peaked at $54.5M in Q1 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.